Please assess the completion status of the following clinical trial:

Trial Title: Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Inoperability, or when a patient refuses surgery (i.e. not eligible for (partial-) nephrectomy or RFA);~* Kidney function allows for intervention, as evaluated by treating urologist (taking into account eGFR and renogram);~* Age ≥ 18 years;~* Written informed consent;~* Diagnosis of RCC confirmed by pathology (in case determined after informed consent, patients who are not eligible anymore (no RCC) will be excluded).~Exclusion Criteria:~* Evidence of metastatic disease;~* Exclusion criteria for contrast enhanced MRI scan, according to the protocol of the department of Radiology, UMC Utrecht;~* Patients with one functioning kidney;~* Prior renal surgery (partial nephrectomy);~* Prior radiotherapy on upper abdomen;~* Unsafe to have fiducial marker implantation: i.e. anticoagulant agents use other than acetylsalicyl acid, which cannot be safely stopped/bridged for implantation:~* WHO ≥ 3.~* Chemotherapy \< 3 weeks before treatment;~* Targeted therapy (sunitinib, etc.) ≤ 7 days before treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- ARREST-study (Type: EXPERIMENTAL): SBRT renal cell carcinoma 5 times 7Gy

Based on this trial design, predict the completion outcome and termination type (if applicable).